Search results
Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 43 minutes agoNet loss: US$26.6m (loss narrowed by 32% from 1Q 2023). US$0.62 loss per share (improved from...
DraftKings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 44 minutes agoNet loss: US$142.6m (loss narrowed by 64% from 1Q 2023). US$0.30 loss per share (improved from...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 minutes agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Codexis First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 hour agoNet loss: US$11.5m (loss narrowed by 49% from 1Q 2023). US$0.17 loss per share (improved from...
Five9 First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 hour agoNet loss: US$7.08m (loss narrowed by 74% from 1Q 2023). US$0.096 loss per share (improved from...
Opendoor Technologies First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 hour agoQuarter 2024 Results Key Financial Results Revenue: US$1.18b (down 62% from 1Q 2023). Net loss:...
Grid Dynamics Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 hour agoQuarter 2024 Results Key Financial Results Revenue: US$79.8m (flat on 1Q 2023). Net loss: US$3.95m (...
PENN Entertainment First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 16 minutes agoNet loss: US$114.7m (down by 122% from US$512.8m profit in 1Q 2023). US$0.76 loss per share (down...
Cloudflare, Inc. (NYSE:NET) Just Released Its First-Quarter Results And Analysts Are Updating Their...
Simply Wall St. via Yahoo Finance· 53 minutes agoThe results overall were pretty much dead in line with analyst forecasts; revenues were US$379m and...
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its...
Simply Wall St. via Yahoo Finance· 50 minutes agoSo it's pretty clear consensus is mixed on Ultragenyx Pharmaceutical after the new consensus...